Bristol Myers Squibb (BMY) Current Deferred Revenue (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Current Deferred Revenue of $156 million in Q2 2026, down 23.2% from $203 million a year earlier and down 7.1% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb reported Current Deferred Revenue of $175 million, down 21.2% from FY2024.
- Annual Current Deferred Revenue has declined for six straight years, with a five-year compound annual growth rate of -13.7% (FY2020 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $222 million in FY2024 (-19.0%), $274 million in FY2023 (-5.2%), $289 million in FY2022 (-12.4%) and $330 million in FY2021 (-9.8%).
- The Q2 2026 figure is the lowest quarterly Current Deferred Revenue since Q1 2019.
- On a year-over-year basis, Current Deferred Revenue has declined for 23 consecutive quarters, with an average decline of 19.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 3.7% in Q1 2023 to 23.2% in Q2 2026.
- Per Business Quant, the preceding three quarters came in at $168 million (Q1 2026), $175 million (Q4 2025) and $190 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.45 Bn | 1,115.03 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 622.49 Bn | 541.02 Bn | 17.26 Bn |
| 3 | AbbVie | 509.47 Bn | 482.58 Bn | 12.70 Bn |
| 4 | Merck | 365.43 Bn | 319.80 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.34 Bn | 261.33 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.32 Bn | 235.01 Bn | 12.86 Bn |
| 7 | Amgen | 235.29 Bn | 190.69 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.80 Bn | 167.99 Bn | 6.22 Bn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn |
| 10 | Bristol Myers Squibb | 125.52 Bn | 76.79 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 156.00 Mn |
| Mar 31, 2026 | 168.00 Mn |
| Dec 31, 2025 | 175.00 Mn |
| Sep 30, 2025 | 190.00 Mn |
| Jun 30, 2025 | 203.00 Mn |
| Mar 31, 2025 | 217.00 Mn |
| Dec 31, 2024 | 222.00 Mn |
| Sep 30, 2024 | 236.00 Mn |
| Jun 30, 2024 | 248.00 Mn |
| Mar 31, 2024 | 263.00 Mn |
| Dec 31, 2023 | 274.00 Mn |
| Sep 30, 2023 | 289.00 Mn |
| Jun 30, 2023 | 300.00 Mn |
| Mar 31, 2023 | 314.00 Mn |
| Dec 31, 2022 | 289.00 Mn |
| Sep 30, 2022 | 304.00 Mn |
| Jun 30, 2022 | 321.00 Mn |
| Mar 31, 2022 | 326.00 Mn |
| Dec 31, 2021 | 330.00 Mn |
| Sep 30, 2021 | 344.00 Mn |
API Access
Bristol Myers Squibb Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();